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Iowa Department of Public Health 
Division of Behavioral Health/Bureau of Substance Abuse  
Opioid Update: June 2020 
 
The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information 
about opioid use and Iowa’s efforts to address the national opioid epidemic. Please feel free to 
submit topics to Julie Jones at julie.jones@idph.iowa.gov.  
 
In this issue:  
 
• Department News 
• Opioid News 




Behavioral Health Resources 
 
In April, IDPH provided a modified version of the Opioid Update newsletter as a behavioral 
health resource of related services available to those working to meet the needs of those 
affected by the current COVID-19 pandemic. For those interested, this edition of the newsletter 




SAMHSA/DEA Guidance for Medication-Assisted Treatment during COVID-19 
 
To reduce potential exposure to COVID-19, on March 16, 2020, the Substance Abuse and 
Mental Health Services Administration (SAMHSA) and the Drug Enforcement Agency (DEA) 
released guidance for Opioid Treatment Programs (OTPs) that allows the following blanket 
exceptions: 
 
• All stable patients in an OTP can receive 28 days of take-home doses of the patient's 
medication for opioid use disorder.  
• Up to 14 days of take-home medication can be provided to those patients who are less 
stable, but the OTP believes can safely handle this level of take-home medication.  
 
In addition to the blanket exception, on March 19, 2020, SAMHSA and the DEA issued 
guidance on prescribing buprenorphine, allowing initial assessments to take place via 
telehealth. As a result, some Iowa provider locations are reporting an increase in the number of 
assessments being conducted. 
 
These exceptions will remain in effect until SAMHSA and the DEA have determined there is no 
longer a need due to the COVID-19 pandemic.  
 
SAMHSA Guidance for Law Enforcement and First Responders Administering 
Naloxone 
 
As the COVID-19 pandemic has spread throughout our country, SAMHSA has received reports 
that some first responders and law enforcement officers have been more reluctant to administer 
naloxone due to fear of potentially contracting the coronavirus. SAMHSA recognizes the 
concerns about COVID-19 exposure and has issued guidance to promote first responder safety. 
 
To read the entire guidance document, please click on the following link: SAMHSA 
 
 
The Opioid Crisis and the Black/African American Population: An Urgent Issue 
 
In a recent publication brief, SAMHSA presents recent data on prevalence of opioid misuse and 
death rates in the Black/AA population; contextual factors & challenges to prevention & 
treatment; innovative outreach & engagement strategies to connect people to evidence-based 
treatment; and the importance of community voice. 
 
To read the entire brief, please click on the following link: An Urgent Issue 
 
SAMHSA Releases Updated TIP 63: Medications for Opioid Use Disorder 
 
SAMHSA recently released an updated edition of the Treatment Improvement Protocol (TIP 63) 
on Medications for Opioid Use Disorder. This TIP reviews the use of the three Food and Drug 
Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone and 
buprenorphine—and the other strategies and services needed to support recovery for people 
with OUD. 
 
To view the entire TIP, please click on the following link: TIP 63 
 
Webinars and Trainings 
 
IDPH Offers Virtual Learning Series 
 
The Virtual Learning Series is a part of the Iowa Department of Public Health initiative that 





• Educate professionals on the unique needs of individuals impacted by behavioral health 
conditions 
• Identify recent trends in substance use and problem gambling 
 
Certificates of Completion, Nursing Contact Hours and Iowa Board of Certification Continuing 
Education Units will be provided to the e-mail provided at registration. There is no fee to attend, 
but pre-registration is required. 
 
For information on registering, please click on the following link: IDPH 
 
Foundation for Opioid Response Efforts 
 
The Foundation for Opioid Response Efforts (FORE) was founded in 2018 as a private, 
national, grant-making foundation focused on addressing the opioid crisis. They offer funding for 
projects from nonprofits, universities and government agencies focused on health care provider 
education, payer strategies, policy and public awareness.  
 
To see a list of available webinars, please click on the following link: FORE  
 
  
 
 
 
